コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 t (eg, medical burden, age at onset of first depressive episode).
2 ssion, which indicates a more severe form of depressive episode.
3 roups all diagnosed with Major Depression or Depressive Episode.
4 r patients with a medication-resistant major depressive episode.
5 sed state and is a potential biomarker for a depressive episode.
6 pectrum disorder, the illness started with a depressive episode.
7 arker for a negative affective bias during a depressive episode.
8 was defined in terms of duration of current depressive episode.
9 nostic Interview criteria for 12-month major depressive episode.
10 apse and recurrence of bipolar type II major depressive episode.
11 resistance, age, and duration of the current depressive episode.
12 emoval of the bereavement exclusion in major depressive episode.
13 to the United States and the odds of a major depressive episode.
14 f a syndromal, hypomanic episode and a major depressive episode.
15 y experienced the onset of their first major depressive episode.
16 ry to enhance vocational functioning after a depressive episode.
17 polar disorder over the 9 months following a depressive episode.
18 ents who were being treated for DSM-IV major depressive episode.
19 a 2-year follow-up of patients with a major depressive episode.
20 e individuals, grief can evolve into a major depressive episode.
21 sed at presentation for treatment of a major depressive episode.
22 r subjects successfully treated for an acute depressive episode.
23 oms than those who had not developed a major depressive episode.
24 its might persist after remission of a major depressive episode.
25 correlated positively with length of current depressive episode.
26 than 20% of females met criteria for a major depressive episode.
27 in the ACC during a moderate to severe major depressive episode.
28 history but who were not in a current major depressive episode.
29 olar I disorder experiencing a current major depressive episode.
30 dequate treatment courses during the current depressive episode.
31 is clinically challenging, especially during depressive episodes.
32 sive episodes and high-risk states for major depressive episodes.
33 of antidepressant drugs in the management of depressive episodes.
34 structures of mixed states based on manic or depressive episodes.
35 reversals one or more of which precipitated depressive episodes.
36 r adults to an increased risk for relapse of depressive episodes.
37 Recurrence was defined in terms of number of depressive episodes.
38 mptoms, depression diagnosis, and cumulative depressive episodes.
39 vidence of bipolarity in patients with major depressive episodes.
40 sociated with higher frequency of subsequent depressive episodes.
41 cant mood symptoms and psychotic symptoms in depressive episodes.
42 a group at very high risk for onset of major depressive episodes.
43 for DSM-IV (SCID) determined incident major depressive episodes.
44 t least 1 syndromal recurrence, particularly depressive episodes.
45 mood disorders has focused largely on major depressive episodes.
46 ning 49% of the variance in the liability to depressive episodes.
47 came depressed during the study had no prior depressive episodes.
48 manic episodes, although it is equivocal for depressive episodes.
49 e, and patient characteristics seen in 9,054 depressive episodes.
50 ssness or excessive guilt during their major depressive episodes.
51 a core role were strongly linked to risk for depressive episodes.
52 ssant drugs can promote remission from acute depressive episodes.
53 anced than simply one of recurring manic and depressive episodes.
54 were seen in time to recurrence of manic and depressive episodes.
55 ants who had experienced a greater number of depressive episodes.
56 or the occurrence, severity, and duration of depressive episodes.
57 he "with mixed features" specifier for major depressive episodes.
58 had at least 1 parent with current or prior depressive episodes.
59 ood and hormone secretion) is altered during depressive episodes.
60 me information for 100 patients with a major depressive episode, 100 with obsessive-compulsive disord
61 sychopathology (187 [29.2%] of 641 for major depressive episode, 146 [22.9%] of 638 for conduct disor
62 ces, with more than twice as many developing depressive episodes (298, 34.7%) as those who developed
63 compared with 4% of the patients with major depressive episode, 3% of those with OCD, and 0% of thos
65 s was as follows: lifetime and current major depressive episode, 35.4% and 14.7%, respectively; suici
67 psychopathology (87 [54.7%] of 159 for major depressive episode, 43 [27.0%] of 159 for conduct disord
68 ad unipolar depression (with a current major depressive episode, a 17-item Hamilton Depression Rating
69 rsus without an antidepressant for a bipolar depressive episode accompanied by > or = 2 concurrent ma
70 er applicable to manic, hypomanic, and major depressive episodes; addition of severity dimensions for
71 ificantly increased the odds of Wave 2 major depressive episodes (adjusted odds ratio (AOR): 1.7; 95%
72 er vulnerability to postpartum triggering of depressive episodes aggregates in families and assess ho
73 thors postulated that among men with a major depressive episode, aggression, hostility, and history o
74 ust, even after adjustment for a prior major depressive episode, alcohol abuse or dependence, and dru
76 eases the risk of suicidal behavior; a major depressive episode also increases the risk for suicidal
79 -IV major depressive disorder during a major depressive episode and 42 healthy volunteers were clinic
80 Twenty-four MDD subjects in a current major depressive episode and 51 previously studied healthy con
81 712 youth with a lifetime history of a major depressive episode and 712 typically developing (TD) you
82 cation-free (ie, untreated) outpatients in a depressive episode and assessed them for cognitive funct
83 f first onset of depressive disorders (major depressive episode and dysthymia) and anxiety disorders
84 in major depressive disorder (MDD) during a depressive episode and following treatment with ketamine
85 ns in 3 categories: (1) mental health (major depressive episode and generalized anxiety disorder), (2
86 , 10th Revision (ICD-10) at age 45 years for depressive episode and generalized anxiety disorder.
87 1 adults who met DSM-IV criteria for a major depressive episode and had Hamilton Depression Rating Sc
88 N = 31) appetite and weight in their current depressive episode and healthy control participants (N =
89 -IV major depressive disorder during a major depressive episode and in 43 healthy volunteer compariso
90 d with depression may precede the onset of a depressive episode and influence the development and cou
91 al practice because onset is most commonly a depressive episode and looks similar to unipolar depress
93 ntreated depressed state seen during a major depressive episode and the pattern of change seen in dep
94 erm memory persist in remission from a major depressive episode and worsen with repeated episodes.
95 h Diagnostic Criteria from their index major depressive episode and/or mania were divided into residu
96 ymptom profiles compared with other types of depressive episodes and are not associated with increase
97 grouped on the basis of the number of prior depressive episodes and current depressive diagnosis.
99 oaching experienced a low incidence of major depressive episodes and exhibited a 40%-50% decrease in
100 , but patients in FFT-A spent fewer weeks in depressive episodes and had a more favorable trajectory
101 pausal age that is also present during major depressive episodes and high-risk states for major depre
102 cy in acute manic episodes, lithium in acute depressive episodes and in prophylaxis of mania and depr
103 t patients with three or more previous major depressive episodes and on a therapeutic dose of mainten
104 ive view of life and the self, more lifetime depressive episodes and suicide attempts, and greater sy
105 Although mania defines bipolar I disorder, depressive episodes and symptoms dominate the longitudin
106 r clinical management are the following: (1) depressive episodes and symptoms, which dominate the cou
108 behaviors (symptomatology and trajectory of depressive episodes) and biology (genetics and sexually
109 ssive symptoms that do not meet criteria for depressive episodes); and bipolar disorder not otherwise
110 alizing (anxiety and eating disorders, major depressive episode, and cluster C, borderline, and paran
112 r age at onset, a greater previous number of depressive episodes, and eight individual symptom items
113 hic mechanisms, the longitudinal dynamics of depressive episodes, and strategies for developing perso
114 ashion with a greater proportion of weeks in depressive episodes, and this relationship persisted ove
115 to assess the primary outcome, new onsets of depressive episodes, and to calculate depression-free da
116 n of severity dimensions for manic and major depressive episodes; and removal of the bereavement excl
117 in the cholinergic system observed during a depressive episode appears to resolve during euthymia.
118 th likely diagnoses of both PTSD and a major depressive episode are at a 4-fold increased risk of pre
119 nality disorder diagnoses established during depressive episodes are a valid reflection of personalit
120 Little is known about how often bipolar depressive episodes are accompanied by subsyndromal mani
121 mania and hypomania define bipolar disorder, depressive episodes are more common and impairing, with
122 patients who, despite full remission from a depressive episode, are at substantial risk of relapse w
123 le and female subjects in both cohorts had a depressive episode as the first episode of bipolar illne
124 safety of standard antidepressant agents for depressive episodes associated with bipolar disorder (bi
125 done in the treatment of patients with major depressive episodes associated with bipolar I disorder.
126 amined suicide attempts included severity of depressive episode at study intake and family history of
128 patients diagnosed with Major Depression or Depressive Episode (average age = 49 +/- 12.9), the seco
129 (MDD) indicate that the onset of subsequent depressive episodes becomes increasingly decoupled from
133 as associated with a greater number of prior depressive episodes but not current depressive diagnosis
134 ry who are at high risk for developing major depressive episode by 3 months' postinjury, which could
135 baseline decreased the risk of having a new depressive episode by 6% (adjusted relative risk = 0.94,
138 ine how cognitive function following a major depressive episode compares with normal function, to spe
139 lative episodes on later CRP, but cumulative depressive episodes continued to predict CRP levels inde
140 agnoses, 2 or more comorbid diagnoses, major depressive episode (current and lifetime), past 30-day s
142 were diagnosed as having unipolar or bipolar depressive episodes defined as moderate or severe by DSM
143 er at least 8 weeks of full remission from a depressive episode (defined as a value of 1 on the weekl
144 ts, who are at an elevated lifetime risk for depressive episodes, demonstrate distinctive patterns of
145 t baseline, 6 weeks, 1 year, and 2 years for depressive episodes, depressive symptoms, sleep quality,
146 ween childhood maltreatment and a subsequent depressive episode diagnosis was moderated by 5-HTTLPR g
147 18 years old who recovered from their major depressive episode during initial open-label fluoxetine
148 ects (16.9%) with prior depression developed depressive episodes during follow-up, compared to only o
149 lifetime mental health service use, and new depressive episodes during the 3-year follow-up period.
150 nt effect was driven by a lower incidence of depressive episodes during the first 9 months after enro
152 lowing disorders: affective disorders (major depressive episode, dysthymia, manic episode), anxiety (
153 1.26, 1.09-1.47, p=0.003), greater number of depressive episodes (eight studies, 4025 participants; 1
157 r cytokines, have been associated with major depressive episodes following the experience of stressfu
158 used to collect feedback on five diagnoses: depressive episode, generalised anxiety disorder, schizo
159 posttraumatic stress disorder (PTSD), major depressive episode, generalized anxiety disorder, and su
160 ed with either the same test(s) as the major depressive episode group or with a standardised test wit
161 imer's disease patients with a current major depressive episode had earlier mean ages at onset, a hig
162 disorder or a history of at least one major depressive episode had lower levels of myo-Inositol comp
163 ent-resistant major depression whose current depressive episode had not responded adequately to treat
166 ts with major depressive disorder in a major depressive episode have fewer serotonin transporter site
167 her personality disorders diagnosed during a depressive episode have long-term outcomes more typical
171 ypomanic episodes (hazard ratio=2.29), major depressive episodes (hazard ratio=1.99), and disruptive
172 ime features were associated with more prior depressive episodes, higher levels of depressive symptom
173 d an additional diagnosis of a current major depressive episode, however PD was the primary diagnosis
175 hazard ratio (HR) of a probable or definite depressive episode (ie, depressive symptom rating score
176 There was a four-fold greater proportion of depressive episode in the SELCoH sample than the APMS sa
177 by stressors such as life events or a major depressive episode in the setting of a propensity for ac
179 nal, and psychosocial predictors of incident depressive episodes in a well-characterized cohort of ol
180 compared with UC in preventing the onset of depressive episodes in at-risk youth over a nearly 3-yea
181 most propitious time to prevent or attenuate depressive episodes in bereaved youth may be shortly aft
182 wed up to age 18, data on the evaluation for depressive episodes in early adulthood, on childhood mal
183 howed a moderate association between PDE and depressive episodes in male (OR, 1.58) and female twins
185 o construct a developmental model to predict depressive episodes in the year before the most recent i
186 orbid substance abuse on recovery from major depressive episodes in these patients has not been adequ
188 sorder was due to more severe and persistent depressive episodes in those with bipolar disorder than
189 he triggering of narrowly defined postpartum depressive episodes in women with recurrent major depres
191 fied based on DSM-III-R criteria for a major depressive episode, in addition to atypical features of
192 least 2 years' duration or had three or more depressive episodes (including the current episode), and
193 anesthetic medication for treatment of major depressive episodes, including those associated with bip
195 the familial transmission of manic and major depressive episodes is independent despite the high magn
196 nformation regarding the presence of a major depressive episode, its duration, and its severity was d
198 a was not associated with lifetime number of depressive episodes, lifetime length of depression, leng
199 s predicted both endpoints, whereas previous depressive episodes, male sex, and suicidality additiona
200 disorder in patients who experience a major depressive episode may lead to inappropriate treatment a
203 BPD subjects (n = 14), subjects with a major depressive episode (MDE) only (n = 14), and healthy cont
204 hors examined whether early onset of a major depressive episode (MDE) predicted a subsequent decrease
205 ckness behaviors that present during a major depressive episode (MDE), such as low mood, anhedonia, a
207 rges, stressors such as life events or major depressive episodes (MDEs) determine the timing of suici
208 esponse occurs in approximately 40% of major depressive episodes (MDEs), and one approach to solve th
209 n markers, including greater number of major depressive episodes (MDEs), longer illness duration, and
210 t central to the diagnosis of unipolar major depressive episodes (MDEs), these symptoms have been fou
214 polar disorder seeking treatment for a major depressive episode (N=314) were followed for 2 years.
215 The authors prospectively studied major depressive episodes occurring within 2 years to determin
216 tatus is associated with increased risk of a depressive episode (odds ratio = 3.0, 95% confidence int
217 risk of developing recurrent and persistent depressive episodes (odds ratio=2.27, 95% confidence int
218 tween 14 medication-free patients in a major depressive episode of at least moderate severity and 13
219 patients presenting for treatment of a major depressive episode of at least moderate severity underwe
221 s in the clinical presentations of the major depressive episodes of Alzheimer's disease patients and
223 shifting hypothesis, which suggests that the depressive episodes of SAD are caused by misalignments b
224 , 2,154 subjects developed a new-onset major depressive episode; of these, 457 subjects switched to a
226 fined as recurrent hypomania without a major depressive episode or with fewer symptoms than required
227 to be moderately stable only in consecutive depressive episodes or if episode severity is considered
228 sion (OR = 1.92; 95%CI = 1.64-2.26), a brief depressive episode (OR = 2.14; 95%CI = 1.88-2.43) or dep
230 confidence interval [CI]: 1.84-2.70), brief depressive episode (OR = 2.48, 95% CI = 2.09-2.95) and d
232 utility (e.g., mixed features specifier for depressive episodes), or problematic implementation (e.g
233 gic model for major depression that predicts depressive episodes over 1 year from 18 risk factors con
234 ms underlying the induction and remission of depressive episodes over time are not well understood.
236 every point across the life course for major depressive episode, panic disorder, and posttraumatic st
237 f past-year mood/anxiety disorder (ie, major depressive episode, phobias, panic, generalized anxiety
239 and who were currently experiencing a major depressive episode received a single ketamine infusion (
240 used QEEG to predict response during a major depressive episode, regardless of patient population, tr
241 cacy in prevention of both manic episode and depressive episode relapse or recurrence and the better
242 rder did not predict time to recovery from a depressive episode relative to no substance use comorbid
243 n with a lifetime history of recurrent major depressive episodes relative to women with no history of
245 bles from 252 eligible studies (11 882 major depressive episode remitters and 8533 healthy controls)
248 -controlled trials in acute, unipolar, major depressive episodes reported over the past three decades
249 rate of any mood episode (RR-any, primary), depressive episode (RR-dep) and manic/hypomanic/mixed ep
251 Alcohol-use disorders are associated with depressive episodes, severe anxiety, insomnia, suicide,
252 nantly depressive, and across both manic and depressive episodes, showing essentially parallel struct
254 se spent nearly three times as many weeks in depressive episodes than did those whose intake episode
259 gy for the assessment and diagnosis of major depressive episodes, the prevalence of major depression
260 ith the probability of recovery from a major depressive episode, there was a significantly greater pr
261 (for example, gray matter thinning during a depressive episode), they may be less optimal for the de
262 the United States for the treatment of major depressive episodes to compare 477 subjects with a diagn
263 ificantly correlated with lifetime number of depressive episodes, trauma score, and anxiety score.
264 ere 395 elderly persons with a current major depressive episode, treated as inpatients or outpatients
265 d 795 patients who were experiencing a major depressive episode (unipolar or bipolar depression) of a
267 jor depressive disorder (MDD) during a major depressive episode using positron emission tomography (P
268 jor depressive disorder (MDD) during a major depressive episode using positron emission tomography im
270 e until 25% of the individuals experienced a depressive episode was 21.4 weeks and until 25% experien
272 tpatients, the total time each had been in a depressive episode was divided into days during which th
273 rence of mania, hypomania, mixed state, or a depressive episode was examined with Cox regression.
275 among patients with comorbid PTSD and major depressive episode was not due to differences in substan
276 entage of adults with new (versus recurrent) depressive episodes was 88.6% in the preadvisory period
279 ee individuals with MDD currently in a major depressive episode were enrolled in an open-label study
281 riteria for bipolar I disorder and a current depressive episode were randomly assigned to receive pla
282 istant major depression experiencing a major depressive episode were randomly assigned under double-b
284 ssion follow-up, the rate and HR of incident depressive episodes were lower for those in the CB preve
285 hose with bereavement-related, single, brief depressive episodes were more likely to experience later
287 s or older, and required new treatment for a depressive episode, were enrolled from 27 sites in the U
288 tor retardation during the most severe major depressive episode, whereas male twins reported more ins
289 rates for women who met criteria for a major depressive episode, which suggests an interaction betwee
291 0 patients with three or more previous major depressive episodes who met remission criteria over a 2-
292 ied an additional 31% of patients with major depressive episodes who scored positive on the bipolarit
293 ere assessed while in remission from a major depressive episode with at least one cognitive test, wit
294 s examined associations between Wave 1 major depressive episode with manic episodes and other psychia
295 polar disorder who achieved remission from a depressive episode with the addition of an antidepressan
296 he consequences of increased appetite during depressive episodes with atypical features are advocated
298 The study evaluated the prevalence of major depressive episodes with psychotic features in the gener
299 with pleomorphic manifestations across major depressive episodes within individual patients with unip
300 therapy after recovery from bipolar II major depressive episode without an increase in hypomanic mood